1. Department of Medicine, University of Hong Kong, Hong Kong, China;
2. Department of Pathology, Tseung Kwan O Hospital, Hong Kong, China;
3. Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Texas;
4. Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas; and
5. Cell Signalling and Integrative Biology Research Cluster, School of Biomedical Sciences, University of Hong Kong, Hong Kong, China